News

26th February 2020

Fujifilm offers Wales preview of new global tech

Global tech giant Fujifilm has given Welsh healthcare professionals an exclusive first look at its latest medical innovation ahead of the product’s global clinical launch. The Japanese multinational photography and imaging company, which is a pioneer in medical imaging and diagnostics equipment, previewed its new artificial intelligence (AI) software, which is integrated into a mobile…

24th February 2020

Jellagen® announces the appointment of new Chairman of the Board, Gregg Sando

Jellagen® Ltd, , the leading provider of next generation collagen products from marine sources, announces the appointment of Gregg Sando as Chairman of the Board and Non-Executive Director. Gregg replaces Stephane Thiroloix who will remain as a non-executive director at Jellagen®. Gregg founded one of the first cancer immunotherapy biotech companies in 2005 and has…

24th February 2020

Jellyfish collagen 3D systems support ovarian cancer cell line proliferation, confirming its suitability for advanced cell culturing applications and provides an excellent alternative to mammalian collagen sources for the culture of human cells

Jellyfish collagen sustains and supports ovarian cancer (OvCa) cell attachment, proliferation, morphology and epithelial to mesenchymal transition markers. Jellyfish collagen is tuneable and non-cytotoxic to (OvCa) cells and can be functionalized to mimic the cancer microenvironment. Adopting jellyfish as a collagen source is sustainable and cheaper than the golden standard material sources derived from mammals…

23rd February 2020

Double success for University drug resistance research

Swansea University research into the threat posed by antifungal drug resistance has been highlighted in two prestigious international journals. Fungal disease now kills more people than malaria or TB and the Centre for Disease Control in the USA recognises emergence of multi-drug resistance in fungi as a high level threat. Dr Josie Parker and Prof…

23rd February 2020

University’s new course gets set to revive city’s pharmacy training tradition

Plans for the launch of Swansea University’s new pharmacy degree programme are now well under way but it won’t be the first time future pharmacists have been trained in the city The University, which is celebrating its centenary this year, is putting the finishing touches to its new MPharm degree which begins in 2021 – 91…

23rd February 2020

Meditech Business TrakCel Appoints New CEO

Medical technology company TrakCel has appointed a new CEO as it looks to its next phase of growth, TrakCel, a leading software developer of orchestration systems for advanced therapies, has announced the appointment of Dr Fiona Withey as chief executive officer and co-founder Ravi Nalliah to the role of chief strategy officer. Cardiff-based TrakCel has…

23rd February 2020

Welsh Meditech Firm Joins Fight to Control Coronavirus

Digital technology developed in Wales could play a leading part in helping doctors stem the spread of the coronavirus epidemic. A Cardiff-based medical technology company, Bond Digital Health, has joined the global effort to tackle the Covid-19 outbreak which has so far claimed more than 2,000 lives. Bond has joined an international consortium led by…

19th February 2020

£250k Investment Boost for Award Winning Biotesting Business

An award winning company that has developed an at-home blood testing kit for athletes has been boosted with a £250,000 investment.
10th February 2020

ABHI Offers Most Competitive Solution for UK Exhibitors at MEDICA 2020

ABHI will once again be leading the largest Pavilion of UK health technology companies at MEDICA 2020, promising the most cost-effective solution for UK companies looking to develop and nurture international trade links at the world’s largest medical trade fair. The UK’s leading HealthTech trade body is ushering in the new decade by announcing their…

10th February 2020

Life science innovation project wins extra €5m investment

A unique Irish-Welsh partnership involving life science expertise at Swansea University has won €5 million of additional funding. The extra money will help the Celtic Advanced Life Science Innovation Network (CALIN) continue to develop the life science sector across the two countries. CALIN is backed by the European Regional Development Fund through the Ireland Wales…